Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1995 Jan 31;92(3):880–884. doi: 10.1073/pnas.92.3.880

Dark-light: model for nightblindness from the human rhodopsin Gly-90-->Asp mutation.

P A Sieving 1, J E Richards 1, F Naarendorp 1, E L Bingham 1, K Scott 1, M Alpern 1
PMCID: PMC42724  PMID: 7846071

Abstract

A human rhodopsin mutation, Gly-90-->Asp (Gly90Asp), cosegregated with an unusual trait of congenital nightblindness in 22 at-risk members of a large autosomal dominant kindred. Although rhodopsin mutations typically are associated with retinal degeneration, Gly90Asp-affected subjects up to age 33 did not show clinical retinal changes. Absolute threshold for visual perception was elevated nearly 3 logarithmic units in 7 individuals tested (ages 11-64), indicating greatly compromised rod threshold signaling. However, in vivo rhodopsin density was normal. Although the 38-year-old proband could not perceive dim lights, his rod increment threshold function was normal on brighter backgrounds. The impaired rod vision for dim but not bright backgrounds is consistent with a mechanism of increased basal "dark-light" from thermal isomerization equivalent to an increase of > 10(4) over that of wild-type rhodopsin. The Gly90Asp mutation on the second transmembrane helix places an extra negative charge in the opsin pocket; this could contribute to partial deprotonation of the retinal Schiff base and thereby increase photoreceptor noise. In vitro evidence had suggested that transducin is activated by the Gly90Asp mutation in the absence of both the retinal chromophore and light, termed "constitutive activity." The apparent preservation of functioning rods despite extensive and lifelong night-blindness in this kindred is inconsistent with one current hypothesis that chronic rod activation from constitutively active mutant rhodopsin necessarily contributes significantly to photoreceptor demise in human retinal dystrophies.

Full text

PDF
880

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alpern M., Dudley D. The blue arcs of the retina. J Gen Physiol. 1966 Jan;49(3):405–421. doi: 10.1085/jgp.49.3.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alpern M., Pugh E. N., Jr The density and photosensitivity of human rhodopsin in the living retina. J Physiol. 1974 Mar;237(2):341–370. doi: 10.1113/jphysiol.1974.sp010485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Alpern M., Thompson S., Lee M. S. Spectral transmittance of visible light by the living human eye. J Opt Soc Am. 1965 Jun;55(6):723–727. doi: 10.1364/josa.55.000723. [DOI] [PubMed] [Google Scholar]
  4. Barlow H. B. The thermal limit to seeing. Nature. 1988 Jul 28;334(6180):296–297. doi: 10.1038/334296a0. [DOI] [PubMed] [Google Scholar]
  5. Barlow R. B., Birge R. R., Kaplan E., Tallent J. R. On the molecular origin of photoreceptor noise. Nature. 1993 Nov 4;366(6450):64–66. doi: 10.1038/366064a0. [DOI] [PubMed] [Google Scholar]
  6. Dryja T. P., Berson E. L., Rao V. R., Oprian D. D. Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness. Nat Genet. 1993 Jul;4(3):280–283. doi: 10.1038/ng0793-280. [DOI] [PubMed] [Google Scholar]
  7. Dryja T. P., McGee T. L., Reichel E., Hahn L. B., Cowley G. S., Yandell D. W., Sandberg M. A., Berson E. L. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature. 1990 Jan 25;343(6256):364–366. doi: 10.1038/343364a0. [DOI] [PubMed] [Google Scholar]
  8. Fain G. L., Lisman J. E. Photoreceptor degeneration in vitamin A deprivation and retinitis pigmentosa: the equivalent light hypothesis. Exp Eye Res. 1993 Sep;57(3):335–340. doi: 10.1006/exer.1993.1132. [DOI] [PubMed] [Google Scholar]
  9. Hood C., Rushton W. A. The Florida retinal densitometer. J Physiol. 1971 Aug;217(1):213–229. doi: 10.1113/jphysiol.1971.sp009567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jacobson S. G., Kemp C. M., Cideciyan A. V., Macke J. P., Sung C. H., Nathans J. Phenotypes of stop codon and splice site rhodopsin mutations causing retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1994 Apr;35(5):2521–2534. [PubMed] [Google Scholar]
  11. Kaushal S., Khorana H. G. Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry. 1994 May 24;33(20):6121–6128. doi: 10.1021/bi00186a011. [DOI] [PubMed] [Google Scholar]
  12. Kemp C. M., Jacobson S. G., Faulkner D. J. Two types of visual dysfunction in autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1988 Aug;29(8):1235–1241. [PubMed] [Google Scholar]
  13. Mullis K. B., Faloona F. A. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol. 1987;155:335–350. doi: 10.1016/0076-6879(87)55023-6. [DOI] [PubMed] [Google Scholar]
  14. Nakayama T. A., Khorana H. G. Orientation of retinal in bovine rhodopsin determined by cross-linking using a photoactivatable analog of 11-cis-retinal. J Biol Chem. 1990 Sep 15;265(26):15762–15769. [PubMed] [Google Scholar]
  16. Rao V. R., Cohen G. B., Oprian D. D. Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature. 1994 Feb 17;367(6464):639–642. doi: 10.1038/367639a0. [DOI] [PubMed] [Google Scholar]
  17. Richards J. E., Kuo C. Y., Boehnke M., Sieving P. A. Rhodopsin Thr58Arg mutation in a family with autosomal dominant retinitis pigmentosa. Ophthalmology. 1991 Dec;98(12):1797–1805. doi: 10.1016/s0161-6420(91)32047-5. [DOI] [PubMed] [Google Scholar]
  18. Ripps H., Brin K. P., Weale R. A. Rhodopsin and visual threshold in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1978 Aug;17(8):735–745. [PubMed] [Google Scholar]
  19. Ripps H. Night blindness revisited: from man to molecules. Proctor lecture. Invest Ophthalmol Vis Sci. 1982 Nov;23(5):588–609. [PubMed] [Google Scholar]
  20. Ripps H., Weale R. A. Rhodopsin regeneration in man. Nature. 1969 May 24;222(5195):775–777. doi: 10.1038/222775a0. [DOI] [PubMed] [Google Scholar]
  21. Sakitt B. Counting every quantum. J Physiol. 1972 May;223(1):131–150. doi: 10.1113/jphysiol.1972.sp009838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Schertler G. F., Villa C., Henderson R. Projection structure of rhodopsin. Nature. 1993 Apr 22;362(6422):770–772. doi: 10.1038/362770a0. [DOI] [PubMed] [Google Scholar]
  24. Sung C. H., Schneider B. G., Agarwal N., Papermaster D. S., Nathans J. Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8840–8844. doi: 10.1073/pnas.88.19.8840. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES